12:00 AM
 | 
May 27, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Halozyme management update

Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif.
Business: Endocrine/Metabolic,...

Read the full 22 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >